A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2009
11/25/2009	CN101584853A Earthworm protein polypeptide preparation
11/25/2009	CN101584679A Novel oral capsule preparation for treating cancer and AIDS
11/24/2009	US7622633 Genetic inhibition by double-stranded RNA
11/24/2009	US7622571 Methods and compositions for Mycoplasma pneumoniae exotoxins
11/24/2009	US7622569 The 98P4B6 gene, its fragment, its encoded protein, variants , or a fragment, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 98P4B6 can be used in active or passive immunization
11/24/2009	US7622556 Modified cytokines for use in cancer therapy
11/24/2009	US7622555 a novel protein (INSP052), identified as an immunoglobulin domain-containing cell surface recognition molecule and to the use of this proteins and nucleic acid sequences from the encoding gene in the diagnosis, prevention and treatment of disease
11/24/2009	US7622551 Leukocyte stimulating peptides
11/24/2009	US7622549 Human telomerase reverse transcriptase polypeptides
11/24/2009	US7622478 Therapy for prostate cancer
11/24/2009	US7622457 Polynucleotides encoding anticoagulant fusion proteins
11/24/2009	US7622455 Methods for slowing familial ALS disease progression
11/24/2009	US7622447 Use of glutathione synthesis stimulating compounds in reducing insulin resistance
11/24/2009	US7622446 Polypeptides, derivatives and uses thereof
11/24/2009	US7622445 Genetically engineered mutant with substituted amino acids; vectors and host cells for propagation of nucleic acid sequences; non-insulin dependent diabetes, hypoglycemic agents; hyperinsulinemia, insulin resistance, obesity, glucose intolerance, metabolic disorders
11/24/2009	US7622444 Methods for using OX-40 ligand to enhance an antigen specific immune response
11/24/2009	US7622443 administering to the mammal with at a site of neoangiogenesis, a pharmaceutical preparation comprising a polypeptide containing a truncated extracellular D1-1 polypeptide
11/24/2009	US7622442 Interacting the immature dendritic cells with an antigen ex vivo so that the surface antigen is presented; inducing maturation ex vivo; and contacting with a modulator comprising TRANCE; an increased viability relative to a control dendritic cell not contacted with TRANCE
11/24/2009	US7622441 Comprising controlled substance and amino acid or polypeptide covalently bound to controlled substance in manner that renders controlled substance pharmacologically inactive; when delivered by oral route controlled substance is released in time-dependent manner by acid hydrolysis and/or enzyme cleavage
11/24/2009	US7622440 Cyclic natriuretic peptide constructs
11/24/2009	US7622439 Method to enhance hemodynamic stability using oxygen carrying compositions
11/24/2009	US7622438 Protein formulation for promoting hard tissue formation
11/24/2009	US7622437 Incorporated into stable, soluble nanoscale particles so that activity is maintained; used to kill tumors, to stop bleeding, as topical hemostatic agents and as reagents in prothrombin time assays; blood disorders
11/24/2009	US7622292 Regulation of human transmembrane serine protease
11/24/2009	US7622289 Ornithine aminotransferase (OAT): a target for anticancer drugs
11/24/2009	US7622272 Treating cell proliferation disease; aberrant fetoplacental growth; cancer
11/24/2009	US7622139 a mixture of calcium phosphate as carriers and effervescent agents such as sodium bicarbonate, used for delivery of bone morphogenic proteins; treatment of bone disorders, bone regeneration, as well as tissue repair and reinforcement of bone fractures; implants and prosthetics
11/24/2009	US7622127 Clostridial toxin derivatives and methods for treating pain
11/24/2009	US7622122 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex
11/24/2009	US7622119 Wilm's tumor amino acid sequences for use as tissue targeted agent for treatment of cell proliferative disorders
11/24/2009	US7622116 Method of treating inflammation using soluble IL-17RCX4
11/24/2009	US7622110 Using interleukin beta specific immunoglobulin as blocking agent and preventative of juvenile idiopathic arthritis
11/24/2009	US7622109 Plant gene and uses thereof
11/24/2009	US7622106 Necrosis assay
11/24/2009	US7622105 Conjugation product of a cytokine selected from tumor necrosis factor and interferon gamma and a ligand of CD13 receptor; antitumor agents
11/24/2009	CA2423384C New cross-linked derivatives of hyaluronic acid
11/24/2009	CA2362153C Antimicrobial/endotoxin neutralizing polypeptide
11/24/2009	CA2350638C Biologically active implants coated with a biodegradable polymer
11/24/2009	CA2338342C Conjugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents
11/24/2009	CA2321938C Poly zinc finger proteins with improved linkers
11/24/2009	CA2303063C Mage-3 peptides presented by hla class ii molecules
11/24/2009	CA2265912C Human bad polypeptides, encoding nucleic acids and methods of use
11/24/2009	CA2257127C Inhibition of ii synthesis
11/24/2009	CA2256391C Anticoagulant peptidyl-arginine aldehyde derivatives
11/24/2009	CA2203182C Remedy for diseases caused by il-6 production
11/24/2009	CA2201105C Inhibitor of stem cell proliferation and uses thereof
11/24/2009	CA2200693C Gp 130 lacking the transmembrane domain
11/19/2009	WO2009140661A1 Method of preventing premature delivery
11/19/2009	WO2009140659A2 Method of treating dyspnea associated with acute heart failure
11/19/2009	WO2009140657A2 Method of treating chronic heart failure
11/19/2009	WO2009140599A1 Treatment of metastatic tumors
11/19/2009	WO2009140598A1 Targeted coagulation factors and method of using the same
11/19/2009	WO2009140573A1 Collagen peptide conjugates and uses therefor
11/19/2009	WO2009140433A1 Method of promoting wound healing
11/19/2009	WO2009140416A2 Treatment for epilepsy
11/19/2009	WO2009140408A2 Metal abstraction peptide (map) tag and associated methods
11/19/2009	WO2009140186A1 Methods of preparing peptide derivatives
11/19/2009	WO2009140140A1 Von willebrand factor (vwf) inhibitors for treatment or prevention of infarction
11/19/2009	WO2009140126A1 Method of administering a therapeutic
11/19/2009	WO2009140015A2 Site-directed modification of factor ix
11/19/2009	WO2009139876A2 Regenerating and enhancing development of muscle tissue
11/19/2009	WO2009139855A2 Pharmaceutical compositions of somatostatin-dopamine conjugates
11/19/2009	WO2009139822A1 Anti-hepcidin antibodies and methods of use
11/19/2009	WO2009139739A1 Compositions comprising a combination of botulinum toxin a and botulinum toxin b for treating conditions characterized by unwanted or excessive presynaptic neuronal activity or secretion
11/19/2009	WO2009139635A1 Polymyxin derivatives and uses thereof
11/19/2009	WO2009139599A2 Cell-permeable p27 recombinant protein, a polynucleotide that codes the same and an anti-cancer composition containing the same as an active ingredient
11/19/2009	WO2009139525A1 An synthetic peptide containing bone forming peptide 1(bfp 1) for stimulating osteoblast differentiation, and pharmaceutical composition comprising the synthetic peptide
11/19/2009	WO2009139497A1 Cbp501 -derived agents and methods based thereon for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents
11/19/2009	WO2009139464A1 Pharmaceutical composition for treatment of dry eye and/or corneal/conjunctival disorders
11/19/2009	WO2009139298A1 Metastin derivative and use thereof
11/19/2009	WO2009138987A2 Molecules interfering with binding of calbindin to inositol monophosphatase for the treatment of mood disorders
11/19/2009	WO2009138762A2 Therapeutic use of peptides
11/19/2009	WO2009138511A1 Long-acting y2 and/or y4 receptor agonists
11/19/2009	WO2009138455A1 Enzyme composition for reducing the release of pharmaceutical active ingredients into the environment
11/19/2009	WO2009138236A1 Novel and powerful mhc-class ii petptides derived from survivin
11/19/2009	WO2009138094A1 Pharmaceutical compositions
11/19/2009	WO2009138042A1 A composition of glycoprotein hormone
11/19/2009	WO2009137897A1 Nanoparticles containing proteolytic enzymes for the treatment of peyronie's disease
11/19/2009	WO2009137881A1 Angiogenin-enriched milk fractions
11/19/2009	WO2009137880A1 Use of angiogenin or angiogenin agonists for treating diseases and disorders
11/19/2009	WO2009137879A1 Orally administrable dosage forms comprising angiogenin and uses thereof
11/19/2009	WO2009137872A1 Methods and compositions for the treatment of cancer
11/19/2009	WO2009137871A1 Methods of detecting cells with a disrupted cell membrane, cells infected with a pathogen, dying cells or dead cells
11/19/2009	WO2009137852A1 Peptides and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
11/19/2009	WO2009137851A1 Peptides and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
11/19/2009	WO2009137850A1 Peptides, peptidomimetics and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
11/19/2009	WO2009123457A3 Ubiquitin alone or in combination for use in the treatment of sweet itch
11/19/2009	WO2009120307A3 Method of treating peripheral arterial disease
11/19/2009	WO2009117480A8 Histidine related compounds for identifying and blocking amyloid beta ion channels
11/19/2009	WO2009116524A9 Modified protein
11/19/2009	WO2009055613A3 Inhibition of urokinase-type plasminogen activator (upa) activity
11/19/2009	WO2009019614A3 Meganuclease variants cleaving a dna target sequence from the human interleukin-2 receptor gamma chain gene and uses thereof
11/19/2009	WO2008147536A8 Methods and compositions for enhancing proteasome activity
11/19/2009	WO2008131940A3 Combination of immunological agent and sensitizing agent for the treatment of cancer
11/19/2009	WO2008129422A8 Demannosylated recombinant factor viii for the treatment of patients with haemophilia a
11/19/2009	WO2005097175A3 Human glp-1 mimetibodies, compositions, methods and uses
11/19/2009	WO2000018211A9 A novel cochlear gene coch5b2 and uses therefor
11/19/2009	US20090287313 Tissue adhesive sealant
11/19/2009	US20090286963 Antigenic fusion protein carrying gal alpha1,3gal epitopes
11/19/2009	US20090286958 Interferon-beta fusion proteins and uses

1 ... 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 ... 3163